| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
Lombardi Cancer Center, Georgetown University, Washington, D.C. 20007
Findings obtained in in vitro assays and animal studies indicate that estrogens might influence the activity of the tumor suppressor gene BRCA1, and BRCA1 in turn may suppress the activity of the estrogen receptor. This review will discuss the possibility that interactions between estrogens and BRCA1 partly explain why elevated circulating estrogen levels appear to increase breast cancer risk among postmenopausal women but not among young women. A hypothesis is proposed that estrogens have a dual role in affecting breast cancer risk. In young women whose breasts have not yet accumulated critical mutations required for cancer initiation and promotion, activation of BRCA1 by estrogens helps to maintain genetic stability and induce differentiation, and therefore estrogens do not increase breast cancer risk. Breasts of older women, in contrast, are likely to contain transformed cells whose growth is stimulated by estrogens. Although BRCA1 is also probably activated by estrogens in older women, its function may have been impaired, for example, due to increased methylation associated with aging. Estrogen exposure in women who carry germ-line mutations in BRCA1 may always increase breast cancer risk because estrogens would be able to cause DNA damage and increase genetic instability without being opposed by BRCA1-induced repair activity. This might lead to an increase in the number of overall mutations, including those that initiate breast cancer. In addition to increasing genetic instability, reduced BRCA1 activity may also be linked to changes in the mammary gland morphology that predispose individuals to breast cancer. For example, a persistent presence of lobules type 1, which are the least differentiated lobular structures in the human breast, is seen in the BRCA1 mutation carriers. The aim of this review is to discuss the role of premenopausal estrogens in breast cancer and to initiate more research that would lead to novel means of reducing breast cancer risk, particularly among BRCA1 mutation carriers.
This article has been cited by other articles:
|
|
 |
|
  A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi Isoflavones in breastfed infants after mothers consume soy. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cousineau, C. Abaji, and A. Belmaaza BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis Cancer Res., December 15, 2005; 65(24): 11384 - 11391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Baer, S. J. Schnitt, J. L. Connolly, C. Byrne, W. C. Willett, B. Rosner, and G. A. Colditz Early Life Factors and Incidence of Proliferative Benign Breast Disease Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2889 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M K Simick and L Lilge Optical transillumination spectroscopy to quantify parenchymal tissue density: an indicator for breast cancer risk Br. J. Radiol., November 1, 2005; 78(935): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, S. Fan, Z. Li, M. Fu, M. Rao, Y. Ma, M. P. Lisanti, C. Albanese, B. S. Katzenellenbogen, P. J. Kushner, et al. Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor {alpha} Activity Cancer Res., August 1, 2005; 65(15): 6557 - 6567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.-A. Gustafsson, G. Khan, and L. Hilakivi-Clarke Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis Carcinogenesis, May 1, 2004; 25(5): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prasad, A. Z. Fernandis, Y. Rao, and R. K. Ganju Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells J. Biol. Chem., March 5, 2004; 279(10): 9115 - 9124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Q. Kuang, L. Liao, H. Zhang, A. V. Lee, B. W. O'Malley, and J. Xu AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice Cancer Res., March 1, 2004; 64(5): 1875 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal Suppression of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis in Rats by Resveratrol: Role of Nuclear Factor-{kappa}B, Cyclooxygenase 2, and Matrix Metalloprotease 9 Cancer Res., September 1, 2002; 62(17): 4945 - 4954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Lin, W.-J. Wang, Y.-H. Wu, and S.-Y. Cheng Activation of Antimetastatic Nm23-H1 Gene Expression by Estrogen and Its {alpha}-Receptor Endocrinology, February 1, 2002; 143(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Roy, G. Calaf, and T. K. Hei Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells Carcinogenesis, October 1, 2001; 22(10): 1685 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 1, 2001; (2001) 171174298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. J. Vaziri, L. M. Krumroy, P. Elson, G. T. Budd, G. Darlington, J. Myles, R. R. Tubbs, and G. Casey Breast Tumor Immunophenotype of BRCA1-Mutation Carriers Is Influenced by Age at Diagnosis Clin. Cancer Res., July 1, 2001; 7(7): 1937 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 14, 2001; 98(17): 9587 - 9592. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
